Document is current
Any future updates will be listed below
-
Authors
Cornelissen, Merel E. B. https://orcid.org/0009-0004-5707-4673
Bloemsma, Lizan D.
Vaes, Anouk W.
Baalbaki, Nadia
Deng, Qichen
Beijers, Rosanne J. H. C. G.
Noij, Lieke C. E.
Houweling, Laura
Bazdar, Somayeh
Spruit, Martijn A.
Maitland-van der Zee, Anke H.
,
- License Information
-
More Information
Article History
Received: 23 December 2023
Accepted: 11 February 2024
First Online: 21 February 2024
Declarations
:
: This study was approved by the ethical board of the Amsterdam UMC, reference number NL74701.018.20. All participants gave their written informed consent.
: Not applicable.
: M.E.B.C., L.D.B., N.B., R.J.H.C.G.B., L.H., L.C.E.N. and A.H.M.: Public and private partners in the P4O2 consortium, as listed under ‘funding’. M.A.S. reports grants from Lung Foundation Netherlands, grants from Stichting Astma Bestrijding, grants and fees from Boehringer Ingelheim, and grants and personal fees from AstraZeneca, outside the submitted work. All payments were done to M.A.S. employer. S.B., A.W.V. and Q.D. declare that they have no competing interests.
